Header Logo

Connection

Mary Jo Fidler to Cyclin-Dependent Kinase Inhibitor p16

Back to Details
This is a "connection" page, showing publications Mary Jo Fidler has written about Cyclin-Dependent Kinase Inhibitor p16.
Mary Jo Fidler
Connection Strength
0.065
Cyclin-Dependent Kinase Inhibitor p16
  1. Clinical features and outcomes in young adults with oral tongue cancer. Am J Otolaryngol. 2019 Jan - Feb; 40(1):93-96.
    View in: PubMed
    Score: 0.042
  2. PTEN, RASSF1 and DAPK site-specific hypermethylation and outcome in surgically treated stage I and II nonsmall cell lung cancer patients. Int J Cancer. 2010 Apr 01; 126(7):1630-9.
    View in: PubMed
    Score: 0.023
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.